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Abstract 
 
Background:  Urinary incontinence (UI) and fecal incontinence (FI) commonly 
occur after stroke and can have significant negative effects on recovery including 
increased care needs and diminished health-related quality of life.  The causes of 
post-stroke UI and FI are multifactorial, and function may be influenced by a variety 
of factors.  This study sought to examine the value of clinical characteristics assessed 
in the immediate post-stroke period to predict continence status at 6 months. 
 
Materials and Methods:  A secondary analysis was performed using the Kansas 
City Stroke Study, a prospective cohort of 459 subjects examined using a battery of 
validated functional assessment tools administered within two weeks after stroke 
(baseline) and at 1, 3, and 6 month intervals.  Continence status was determined 
using the Barthel Index items for bladder and bowel function.  Inclusion criteria for 
this secondary analysis required subjects to have been continent and fully 
independent of both bladder and bowel prior to stroke, and to have completed the 6 
month follow-up examination.  Predictor variables measured at baseline were 
compared to continence outcomes at 6 months using bivariate analyses adjusted for 
stroke severity and multiple logistic regression models. 
 
Results:  A total of 321 subjects met inclusion criteria.  At 6 months, 64 had UI and 
48 had FI, including 28 who had dual incontinence.  Using multiple logistic 
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regression models, independent predictors of UI at 6 months included age and the 
presence of UI at baseline enrollment.  For FI, independent predictors included age, 
stroke severity, visual impairment, and lack of independence for dressing at baseline 
enrollment. 
 
Conclusions:  Urinary and fecal incontinence are common after stroke.  Several 
clinical variables which can be measured in the immediate post-stroke period can be 
used to help predict subsequent bladder and bowel continence status within 6 months 
after stroke.
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Introduction  
 
Urinary and fecal incontinence represent major causes of morbidity and 
disability among acute stroke survivors.  The associated physical, psychosocial, and 
economic impacts for patients and their caregivers can be significant.  Urinary and 
fecal incontinence are among the leading diagnoses ultimately leading to nursing 
home placement in the United States.  Efforts to prevent or reduce the incidence of 
both urinary and fecal incontinence in the general population and also in specific 
clinical conditions have recently gained increased research attention.1  The purpose 
of this study was to examine if clinical characteristics which can be measured in the 
immediate post-stroke period can be used to predict bladder and bowel continence 
status at 6 months after stroke.  It is possible that these clinical factors could be 
potential targets for therapeutic intervention which might have significant impacts on 
rehabilitation efforts.  Improvement in urinary and fecal continence status after 
stroke could lead to decreases in overall caregiver burden, enhancements in 
functional status and better quality of life for post-stroke survivors.  In addition, 
enhanced continence status could lead to lower rates of healthcare resource 
utilization, including decreased need for nursing home admission.  This could have a 
significant cost impact for society and our healthcare delivery system. 
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Background and Clinical Significance 
 
Urinary Incontinence 
 Urinary incontinence has been defined by the International Continence 
Society as the ‘complaint of any involuntary leakage of urine.’ 2, 3  Urinary 
incontinence may be either chronic or transient.  Transient urinary incontinence is 
often caused by extrinsic factors which influence bladder function such as urinary 
tract infection, delirium, diuretic use, or fecal impaction.  Correction of the 
underlying etiology often leads to complete resolution of the incontinence symptoms.  
Chronic incontinence tends to be more problematic, and may be more difficult to 
treat.  Medical, surgical, and biobehavioral therapies are all used in the management 
of chronic urinary incontinence. 
 Various forms of urinary incontinence are defined by the International 
Continence Society.2, 3  Stress incontinence is an ‘involuntary leakage on effort or 
exertion, or on sneezing or coughing.’  It is caused by an increase in intra-abdominal 
pressure which exceeds the resistance at the bladder outlet.  Anatomic defects 
including intrinsic urethral sphincter deficiency in men or women, or urethral 
hypermobility in women predispose to stress urinary incontinence symptoms.  Urge 
urinary incontinence is defined as ‘involuntary leakage accompanied by or 
immediately preceded by urgency.’  The most common cause is involuntary 
contraction of the detrusor muscles with bladder filling.  Detrusor instability or 
hyperreflexia with associated urinary urge incontinence is a common urodynamic 
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finding in subjects with post-stroke urinary incontinence.  Many patients experience 
mixed urinary incontinence with both stress and urge symptoms.  ‘Overflow 
incontinence’ refers to involuntary leakage which occurs when the bladder is full and 
is usually associated with poor bladder emptying during the voiding effort.  This is 
most typically caused by detrusor hypocontractility.  Obstruction of the urethral 
outlet, including benign prostatic hyperplasia, bladder neck contracture, or urethral 
stricture disease, may also cause incomplete emptying and overflow urinary 
incontinence.  Many patients with overflow incontinence experience some change in 
bladder sensation.  The term ‘functional incontinence’ refers to urinary incontinence 
associated with factors extrinsic to the bladder which cause problems with chronic 
urinary leakage.  Impairments of mobility and cognition are the two major causes of 
functional incontinence.  ‘Nocturnal enuresis’ refers to the involuntary leakage of 
urine during sleep. 
 The overall prevalence of urinary incontinence among community dwelling 
adults has been reported to range from 9% to 69% of all women, and 17% to 58% of 
women over the age of sixty.4  The prevalence in males is lower, with reported 
ranges from 1% to 28% of community-dwelling men experiencing chronic urinary 
incontinence.  A recent health care utilization analysis revealed that approximately 
17% of men over sixty years of age experience chronic urinary incontinence.5, 6  
Although the overall prevalence of urinary incontinence increases with age, most 
experts agree that age itself is not the primary cause of the problem.  Rather, it is the 
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increased comorbidity in older adults that may predispose them to problems with 
urinary incontinence. 
 The prevalence of urinary incontinence in nursing home residents is 
significantly higher compared to older adults living in the community.  Urinary 
incontinence is often cited as one of the primary etiologic factors necessitating 
nursing home admission in the United States.  In one study of 430 new patients 
admitted to nursing homes, 39% of both men and women were found to be 
incontinent of urine.7  The prevalence of urinary incontinence has been reported to 
be has high as 43.8% at one year after admission to nursing homes.8  A recent health 
care utilization analysis examined rates of urinary incontinence using data from the 
National Nursing Home Survey.  In this study, more than 50% of female nursing 
home residents were reported to have difficulty controlling urine, and a similar 
number needed assistance to use the toilet.9 
 The economic impact of urinary incontinence is staggering.  It is estimated 
that the overall cost of urinary incontinence care in the United States is 
approximately $19.5 billion (year 2000 dollars).10  Of this, approximately $14.2 
billion was spent on community-dwelling subjects, and $5.3 billion on institutional 
residents.  Expenditures for urinary incontinence care have increased sharply over 
the past decade.11  Among female Medicare beneficiaries over 65 years of age, the 
annual expenditure for urinary incontinence care rose from $128.1 million in 1992 to 
$234.4 million in 1998.   This was due primarily to the rise in outpatient medical 
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costs, and accounted for 27.3% of total health care expenditures in women over 65 
years of age in 2000. 
 Urinary incontinence can also have significant negative impacts on health-
related quality of life and psychosocial health.  Urinary incontinence may be 
associated with decreased social engagement and participation in activities which in 
turn can lead to decreased self-esteem and increased rates of depression.12  Even in 
cases where urinary incontinence does not impact social interaction or activities, 
incontinent individuals often report higher rates of loneliness and depression.13  In 
addition, urinary incontinence adds a significant burden to the caregiving process by 
increasing the amount of time and costs associated with clinical care.14  This may 
also have strong negative effects for those who provide clinical assistance for an 
incontinent person.15 
Although urinary incontinence has been identified as a marker of frailty 
among community-dwelling elders, its relationship to mortality is more 
controversial.  Some studies have found worsening urinary incontinence to be a 
significant risk factor for death16, but other research studies have not supported this 
relationship.17, 18 
 
Fecal Incontinence 
 Definitions of fecal incontinence have yet to be standardized in the research 
literature.  Recent consensus conferences on incontinence organized by the World 
Health Organization (WHO) included committees to examine the problem of anal 
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incontinence.  They proposed that anal incontinence be defined as, ‘the involuntary 
loss of flatus, liquid or solid stool that is a social or hygienic problem.’ 19, 20  Most 
research studies on fecal incontinence exclude those with loss of flatus alone, and 
include only subjects who experience involuntary loss of liquid or solid stool.  
Depending on the specific research design and the study population analyzed, 
estimates of the prevalence of fecal incontinence in the general community-dwelling 
adult population vary widely, with reported ranges between 2% and 26%. 21-23 
 Much like urinary incontinence, fecal incontinence is associated with 
significant negative impacts on health-related quality of life and social engagement.  
The condition is often associated with feelings of panic and a reluctance to go out in 
public.24  Older adults with fecal incontinence also experience high levels of anxiety 
and depression compared to subjects without this problem.25  There is evidence to 
suggest this may be linked to the associated degree of fecal soiling in stroke 
survivors.26 
 It is estimated that approximately 50% of nursing home residents suffer from 
some degree of fecal incontinence.27, 28  There is a strong overlap with urinary 
incontinence.  In fact, most nursing home residents with fecal incontinence also 
experience urinary incontinence.29  Fecal incontinence can significantly increase the 
risk of developing perineal skin breakdown and wound complications.  There is 
evidence to suggest that fecal incontinence may be associated with an increased risk 
of mortality.16 
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Research on fecal incontinence has been more limited compared to work on 
urinary incontinence.  Additional studies are needed to better understand both the 
etiologic mechanisms and potential therapeutic interventions for this condition.30 
 
Stroke 
 Stroke is caused by an acute disruption of the blood supply to the brain.  This 
may be due to either ischemic or hemorrhagic factors.  When symptoms are caused 
by an ischemic event and last for less than twenty-four hours, the diagnosis is a 
‘transient ischemic attack’ (TIA).  The World Health Organization (WHO) defines 
stroke as a condition of ‘rapid onset and of vascular origin reflecting a focal 
disturbance of cerebral function, excluding isolated impairments of higher function 
and persisting longer than 24 hours.’ 31  Stroke can lead to significant physical 
impairments including problems with urinary and fecal incontinence, difficulty 
walking, cognitive changes, and disorders of speech and language. 
 The overall prevalence of stroke in the United States population is estimated 
at 5.5 million adults.  The incidence of stroke in the United States is approximately 
700,000 per year, with 500,000 of these being first attacks.32  Stroke is the third 
leading cause of mortality in this country, accounting for approximately 1 in 15 
deaths.  It is estimated that 8% to 12% of those suffering an ischemic stroke and 37% 
to 38% of those who experience a hemorrhagic stroke will die within thirty days of 
the stroke event.33  Stoke severity is closely linked to associated mortality. 
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In recent years, there have been numerous efforts to enhance public 
awareness of the risk factors for and clinical signs and symptoms of stroke.  This has 
led to earlier intervention and development of related therapies such as statin 
medications for stroke prevention34 and tissue plasminogen activator and similar 
thrombolytic agents for use in ischemic stroke.35, 36 
 However, these improvements in stroke survival have been accompanied by 
increased rates of morbidity and disability.37  In fact, stroke is one of the leading 
causes of serious chronic disability in the United States.  In 1999, it was estimated 
that approximately 1.1 million adults experienced some type of functional limitation 
or impairment of activities of daily living (ADLs) due to stroke.38  The psychological 
and socioeconomic impacts of stroke can be significant.  Stroke has been linked to 
depression, although the direction of causality is incompletely understood.39  Even 
though up to 65% of stroke survivors are functionally independent at one year, the 
overall socioeconomic burden is significant.40, 41  The estimated costs, including both 
direct and indirect costs, of caring for stroke survivors in the United States in 2006 
was $57.9 billion.32  The estimated mean lifetime cost of an ischemic stroke has been 
estimated at approximately $140,000 (in 1999 dollars).42  It is predicted that these 
figures will continue to rise as the absolute incidence of stroke increases.40 
 
Post-Stroke Incontinence 
 Urinary incontinence can negatively influence overall quality of life after 
stroke.43  In a study of 361 community-dwelling stroke survivors, 16% were found to 
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experience urinary incontinence based on assessment using the Functional 
Independence Measure™ (FIM).44  Subjects who reported experiencing at least one 
episode of urinary leakage each month were found to have significantly diminished 
health-related quality of life and decreased levels of participation in social activities 
compared to those who did not leak urine.  These findings were independent of 
stroke severity.   Post-stroke fecal incontinence is also associated with significant 
impairments in health-related quality of life.26 
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Conceptual Framework 
 
Development of this research project was based on a conceptual framework 
to describe the complex interactions between various aspects of an individual’s 
health.  Baseline functional status for any individual varies in terms of overall 
physical, cognitive, and emotional status.  Most of these factors are measurable, and 
some may change over time and in response to various stressors.  After an acute 
stroke, there are alterations in many of these factors which can lead to a change in 
overall post-stroke functional status.  In turn, this can significantly influence the need 
for post-stroke rehabilitation and other clinical care.  This concept is summarized in 
Figure 1: 
Baseline 
Functional 
Status 
STROKE 
? 
Clinical variables 
affecting outcomes 
Post-Stroke 
Functional 
Status 
Rehabilitation and 
Clinical Care Needs
Figure 1 – Conceptual Model of the Progression of Functional Status After Stroke 
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The interactions between the many variables which could influence outcome after an 
acute stroke are complex and multidirectional.  Some variables such as age, sex, and 
race/ethnicity are fixed and do not change for a given individual.  Other variables are 
more fluid, and will vary in relation to improvement or deterioration in other areas 
such as physical mobility, cognitive status, and emotional state.  Indeed, multiple 
contributing factors are involved in each of these broad clinical domains.  A 
generalized concept of how these types of variables interact and how they could 
potentially influence urinary and/or fecal continence status is presented in Figure 2: 
Cognition Continence 
Mobility Depression 
 
Figure 2 – Conceptual Model of the Potential Interactions Between Various Clinical 
      Domains and Urinary and/or Fecal Continence Status 
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Specific Aims 
 
 Based on the previously described conceptual framework, and the hypothesis 
that urinary and fecal continence status after stroke are influenced by multiple 
factors, this study was designed to address three specific aims: 
Specific Aim #1:  To identify clinical characteristics which can be assessed 
in the immediate post-stroke period that may be predictive of urinary (bladder) 
continence status at six months after stroke. 
Specific Aim #2:  To identify clinical characteristics which can be assessed 
in the immediate post-stroke period that may be predictive of fecal (bowel) 
continence status at six months after stroke. 
Specific Aim # 3:  To identify if urinary and/or fecal incontinence at 6 
months after stroke are associated with worse cognitive impairment, physical 
impairment, or depression at that time. 
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Materials and Methods 
 
Original Clinical Dataset 
 The Kansas City Stroke Study (KCSS) served as the clinical population for 
this analysis.  The current research project involved a secondary examination of this 
dataset.  Details regarding the KCSS have been previously published.45  Briefly, the 
KCSS was a prospective, longitudinal cohort study of 459 subjects who suffered an 
acute stroke, and were recruited to participate.  Case enrollment was initiated in 
October 1995, and concluded in March 1998.  Subjects were recruited from one of 
twelve participating health care facilities in the Kansas City metropolitan area.  
These facilities included one tertiary academic medical center, two Veterans Affairs 
hospitals, two inpatient rehabilitation hospitals, and nine regional primary or 
secondary medical centers.  Potential subjects were identified by a review of daily 
facility admission records, referrals from physicians, therapists, or clinical nurse 
specialists on the medical, neurological, and rehabilitation units, and review of 
hospital discharge codes. 
 To be eligible for KCSS study participation, subjects had to have a confirmed 
stroke as defined by the World Health Organization (WHO) criteria.31  This required 
an event with ‘rapid onset and of vascular origin reflecting a focal disturbance of 
cerebral function, excluding isolated impairments of higher function and persisting 
longer than 24 hours.’  Stroke was confirmed by clinical evaluation and/or brain 
imaging with either computed tomography (CT) or magnetic resonance imaging 
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(MRI).  Prior to obtaining consent for enrollment in the study, the physical therapist 
or clinical nurse specialist from the study team reviewed the pertinent medical 
records and conducted interviews of both patients and their physicians. 
 Predefined exclusion criteria included: 1) subjects less than eighteen years of 
age at the time of stroke; 2) stroke onset more than fourteen days prior to study 
screening; 3) stroke caused by subarachnoid hemorrhage; 4) history of hepatic 
failure; 5) history of renal failure or subjects currently undergoing dialysis; 6) history 
of heart failure categorized as New York Heart Association functional grade III or 
grade IV (inability or marked limitations to perform physical activity without 
discomfort due to cardiac etiology); 7) those not expected to survive for more than 
six months; 8) those who lived in a nursing home prior to their stroke; 9) those 
unable to take care of their own affairs prior to their stroke; 10) subjects who were 
lethargic, obtunded, or comatose; 11) and subjects who lived more than seventy 
miles from the participating health care facility. 
 Eligible subjects who agreed to participate were enrolled in the study.  All 
subjects and/or their designated proxies signed informed consent to participate.  
Standardized assessments were completed at baseline enrollment (within 14 days of 
stroke), and at intervals of one, three, and six months.  All assessments were 
completed by trained nurses or physical therapists who were members of the study 
staff.  Each study nurse or physical therapist completed at least two weeks of training 
in the administration of the assessment tools.  In addition, each nurse or physical 
therapist was certified in the administration of the U.S. National Institutes of Health 
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Stroke Scale (NIHSS)46 and the Functional Independence Measure™  (FIM).47  
Detailed information regarding the timing and methods of data collection for the 
Kansas City Stroke Study population have previously been reported.45, 48  
 
Current Secondary Analysis 
Data for this specific study were extracted from the full KCSS database.  The 
dataset was stripped of any information which could be used to personally identify 
specific individuals, and each subject was then assigned a unique identifier to permit 
data tracking through the course of the study.  Variables of interest were selected a 
priori based on a review of the prior published literature on post-stroke incontinence 
and the conceptual framework illustrated in Figure 2. 
 
Additional Inclusion and Exclusion Criteria 
 To be included in the current secondary analysis, subjects had to be 
completely independent of both urinary and fecal function prior to their stroke.  This 
was determined using the reported pre-stroke Barthel Index subscores for bladder 
and bowel function.  Subjects also had to have successfully completed the final 6 
month follow-up visit, with Barthel Index subscore data available for both bladder 
and bowel status at that time point. 
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Dependent Variables 
 The subscores for bladder and bowel function from the Barthel Index (full 
instrument described in the next section) were utilized as the dependent variables for 
this study.  Data for each of these variables were dichotomized into categories of 
incontinent (wet) and continent (dry).  A weighted subscore of 10 points meant that 
subjects were able to control their bladder or bowel during both the day and night, 
were able to independently use an ostomy device or other continence appliance if 
necessary, and stayed dry both day and night.  These subjects were considered 
continent (dry) of bladder or bowel.  A weighted subscore of 5 points meant that 
subjects experienced occasional accidents, could not wait for help or get to the toilet 
in time, or needed help with ostomy or other continence devices.  A weighted 
subscore of 0 meant that subjects could not meet the measurement criteria or were 
incontinent of urine or feces.  For purposes of this analysis, subjects who had 
weighted subscores of either 0 or 5 points were considered incontinent (wet) of 
bladder or bowel.  The associations between the independent predictor variables, and 
the bladder and bowel continence status at 6 months post-stroke were analyzed 
separately.  An additional analysis of the associations between bladder and bowel 
outcomes was also performed. 
 
Independent Variables 
Variables examined included sex, age at the time of stroke, race/ethnicity, 
education, and living situation.  Race/ethnicity was determined based on self-
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described categories including white/Caucasian, black/African American, Hispanic, 
Asian, Native American, or other.  Due to the small numbers of subjects in some 
groups, the race/ethnicity variable was collapsed into three categories including 
white/Caucasian, black/African American, and other.  Educational status was coded 
based on the self-reported highest level of education completed.  For purposes of this 
analysis, educational status variables were collapsed into three categories including 
elementary school (grades 1-11), high school (completed grade 12 or a general 
education development (GED) test), and college or post-graduate training.  Living 
situation was categorized into three groups including subjects living alone, subjects 
living with a spouse, relative, or friend, and subjects with other living arrangements. 
Clinical variables examined included stroke characteristics, measures of 
depression, cognition, and functional status, and presence of comorbid disease.  
These variables were assessed at the initial baseline enrollment for KCSS.  This 
examination was performed within 14 days of the acute stroke.  Stroke type was 
determined based on the vascular etiology of the event (ischemic or hemorrhagic).  
Stroke location was categorized as right cerebral hemisphere, left cerebral 
hemisphere, brain stem, or cerebellum.  Subjects could have experienced stroke in 
one or more locations, and all involved brain areas were coded for each subject.  
Anatomic location was confirmed with brain imaging using either computed 
tomography (CT) or magnetic resonance imaging (MRI). 
 Stroke severity was measured using two different assessment tools.  The 
Orpington Prognostic Scale (OPS) is a multidimensional stroke severity scale which 
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examines several functional domains including motor deficits in the arm, 
proprioception, balance, and cognition.49, 50  Weighted points are assigned for each 
domain based on the level of deficit, and the domain scores are added to a base of 1.6 
points.  Total scores range from 1.6 to 6.8 points with higher scores representing 
more severe stroke.  Prior studies have validated the categorization of stroke severity 
based on these scores and these have shown utility in clinical analysis.45  Based on 
these criteria, stroke severity was categorized as a minor stroke (Orpington score < 
3.2), moderate stroke (Orpington score 3.2 – 5.2), or severe stroke (Orpington score 
> 5.2).  The National Institutes of Health (NIH) Stroke Scale was also assessed at 
baseline.46  This instrument classifies stroke severity based on 11 domains including 
level of consciousness, gaze, vision, facial palsy, motor function, sensory function, 
limb ataxia, language and dysarthria, and extinction or inattention.  Points are 
assigned based on degree of deficit, with total scores ranging from 0 to 42 points.  
Higher scores represent more severe stroke.  This measurement was analyzed as a 
continuous variable. 
 To assess the impact of visual changes on clinical outcomes, the visual 
component subscore of the NIH Stroke Scale was coded for each subject at the time 
of baseline evaluation.  The technique categorizes visual status as normal, partial 
hemianopia, complete hemianopia, or bilateral hemianopia (blind).  To determine the 
influence of extinction or inattention (formerly called ‘neglect’), the 
extinction/inattention component subscore of the NIH Stroke Scale was identified at 
baseline for each subject.  This was categorized as normal, mild 
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extinction/inattention, or profound extinction/inattention.  Data for the visual and 
extinction/inattention component subscores was treated as missing if the data were 
known to be missing for a given subject, or if their status was unknown.  In cases 
where the test was originally described as ‘contraindicated’, data were recoded to the 
worst level of function for that variable. 
The presence and severity of other coexistent health conditions for each 
subject at the time of stroke were assessed using the Charlson Comorbidity Index.51  
This is a standardized, validated instrument designed to measure the degree of 
disease burden and comorbidity for individual patients.  The tool was originally 
designed to help predict mortality risk.  Weighted points are assigned for each 
condition based on the severity of the disorder and the potential for impact on 
mortality.  Each comorbid condition is assigned 1, 2, 3, or 6 points, and the points 
are summed to determine a total comorbidity score.  Higher scores represent more 
numerous or more severe coexistent illnesses.  This parameter was considered as a 
continuous variable in this analysis. 
Depression at both baseline and 6 month follow-up was assessed using the 
Geriatric Depression Scale (GDS).52, 53  This is a 15-item, validated instrument which 
uses yes/no questions to help screen for possible depression.  Scaled scoring is 
utilized to prevent directional response bias in the answers to the questions.  A total 
score is calculated by summation of the scored and reverse-scored items.  The range 
of possible scores is 0 – 15 points.  Scores of 0 – 5 points are considered non-
depressed, while scores > 5 points indicate possible depression.   
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Cognitive status was measured using the Folstein Mini Mental State 
Examination (MMSE).54  This is a standardized, validated assessment instrument 
which is widely used in clinical practice, particularly in geriatrics and neurology.  
The instrument contains 13 questions which are broken into several domains of 
cognition.  Items are scored individually and added together to determine a total 
MMSE score.  Scores range from 0 – 30 points, with higher scores representing 
better overall cognitive function.  Total scores of 24 – 30 are considered normal, and 
scores < 24 indicate cognitive impairment.  For purposes of this analysis, the Folstein 
MMSE was considered as a continuous variable. 
Physical functional status was determined using the Barthel Index.55  This is a 
validated, multidimensional assessment instrument which measures levels of 
physical disability using a 10 item survey of activities of daily living and mobility.  
Specific items about activities of daily living include feeding, bathing, grooming, 
dressing, and toilet use.  Mobility is measured by questions about transfers from a 
bed to a chair and back to bed, the ability to use stairs, and mobility on level 
surfaces.  Two questions address continence status of bladder and bowels.  Weighted 
points are assigned for each question based on the level of independence a person 
has for each specific activity being assessed.  The total Barthel Index score ranges 
from 0 to 100, with higher scores representing better levels of independence and 
physical function.  The Barthel Index has been widely used as an assessment tool in 
clinical rehabilitation, and for research related to stroke outcomes. 
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In order to assess the effects of overall physical function on urinary and fecal 
incontinence, these continence components needed to be removed from the measure 
for this independent variable.  In order to correct for this confounding, a partial 
Barthel Index score, excluding urinary and fecal continence status, was created by 
taking the total Barthel Index score and subtracting the points assigned for these two 
components.  The range for this calculated score is 0 to 80, with higher scores 
representing a greater degree of physical function and independence.  This calculated 
score was examined in the outcomes analysis as a continuous variable.   
 
Institutional Review 
 The original Kansas City Stroke Study was approved by the institutional 
review boards of the sponsoring institution and each of the other eleven participating 
health care facilities.  The secondary data analysis presented in this study was 
reviewed and approved by the University of Kansas human subjects committee.  The 
study was granted exempt status for informed consent because it was an analysis of 
de-identified, coded data.  
 
Statistical Methods 
 Simple descriptive statistics were used to characterize the study population as 
well as the groups of subjects excluded from the outcomes investigation.  Analysis of 
the retained study population was performed by comparing groups who were 
continent versus incontinent at 6 months after stroke.  Separate analyses were 
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performed using either urinary continence status or fecal continence status as the 
outcome variable.  Comparisons between groups were performed using t tests for 
continuous variables and chi-square or Fisher’s exact test as indicated for categorical 
variables.  Non-parametric tests were used when sample normality was not observed.  
Based on the conceptual framework illustrated in Figure 2, bivariate analyses were 
performed to examine if clinical factors measured at the time of enrollment (within 
14 days after stroke) were associated with either urinary or fecal continence status at 
the 6 month follow-up.  Because stroke severity is known to exert such a strong 
influence on subsequent clinical outcomes, data were reanalyzed controlling for this 
factor.  The categorical grade of stroke (minor, moderate, or severe) based on the 
Orpington Prognostic Scale was utilized for this purpose.  Adjusted odds-ratios were 
calculated for each appropriate variable.  Tests for homogeneity across strata were 
also performed (data not shown).  Significance levels of the stratified analyses were 
determined using the Cochran-Mantel-Haenszel statistic.56, 57  Factors found to be 
significant at the p ≤ 0.1 level were entered into multiple logistic regression models 
to identify independent predictors of either urinary or fecal continence status.  
Separate models were created for each of these two outcome variables. 
Because information on depression at the baseline examination was missing 
for 40 subjects (12.5%), two sets of analyses were performed for each outcome 
variable during multiple logistic regression modeling.  In the first set of models, all 
subjects with missing data were categorized as non-depressed.  A second set of 
models was created with these subjects re-categorized as depressed.  Using these best 
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case and worst case scenarios, results were compared between models.  Exploratory 
full models were created initially.  Based on the conceptual framework illustrated in 
Figure 2, models were developed using main effects analyses.  Tests for 2-way 
interactions for all of the variables included in the model were also performed (data 
not shown).  Subsequent multiple logistic regression analyses were performed using 
a backward, stepwise elimination technique.  The analyses were created to model for 
predictors of either urinary or fecal incontinence (wet) status at 6 month follow-up.  
Variables were retained in the model at a p ≤ 0.05 level. 
 Statistical analyses were performed using SAS version 9.1 (SAS Institute, 
Cary, North Carolina). 
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Results 
 
 The full Kansas City Stroke Study dataset included 459 subjects who met 
inclusion criteria and completed the baseline enrollment evaluation.  Using the pre-
defined inclusion and exclusion criteria for the current secondary analysis, a total of 
138 subjects were excluded from this study.  Subject flow is summarized in Figure 3 
(page 69).  Of the 459 total subjects, 73 were excluded because they were either 
incontinent or not completely independent of bladder and/or bowel function prior to 
their stroke (46 incontinent of urine only, 15 incontinent of stool only, and 12 
incontinent of both urine and stool).  Fifty-five of these subjects did complete the 6 
month follow-up examination.  Of the other 18 subjects excluded for a history of pre-
stroke incontinence, 9 died prior to completion of the study, 4 refused continued 
participation, and 5 moved.  Of the 386 remaining subjects, an additional 64 were 
excluded from the current analysis because they did not complete the entire 6 month 
study (23 died, 33 refused, 7 moved, 1 unknown).  One additional subject who did 
complete the final 6 month follow-up was excluded because data on urinary and 
fecal continence status were missing for that visit. The remaining 321 subjects form 
the basis for this research study.  
 Selected demographic and clinical characteristics of the retained and 
excluded cohorts are summarized in Table 1.  Of note, the excluded subjects were 
significantly older, and were more likely to have suffered a severe stroke or a 
brainstem stroke compared to the retained cohort. 
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Demographic and Clinical Characteristics of the Retained Cohort 
 The 321 subjects in the current secondary study included 157 men and 164 
women.  The mean age at the time of stroke was 68.4 ± 11.1 years, with a range from 
42 to 92 years.  The majority of subjects were white/Caucasian (80.4%) or 
black/African American (16.5%).  Only 3.1% of subjects represented other 
racial/ethnic groups (6 Hispanic, 2 Asian, 2 ‘other’).  Subjects were relatively well-
educated with 53.2% having completed high school or a GED, and 24.6% having 
additional college or post-graduate education.  The majority of subjects lived with a 
spouse, other relative or friend (72.6%).  Eighty-four subjects (26.2%) lived alone at 
the time of enrollment. 
 The majority of subjects experienced an ischemic stroke (93.8%).  In most 
cases, the stroke was isolated to only one anatomic location within the brain (156 left 
cerebral hemisphere, 136 right cerebral hemisphere, 18 brainstem, 7 cerebellum).  
However, 4 subjects experienced ischemic strokes involving two different anatomic 
locations (2 right cerebral hemisphere and cerebellum, 1 left cerebral hemisphere and 
cerebellum, and 1 both right and left cerebral hemispheres).  The mean NIH Stroke 
Scale score for stroke severity was 6.4 ± 4.9 (range 0 – 31).  The mean Orpington 
Prognostic Scale score was 3.5 ± 1.2 (range 1.6 to 6.8).  Based on the OPS 
categorical scores, 43.9% of subjects experienced a minor stroke, 47.4% experienced 
a moderate stroke, and 8.7% experienced a severe stroke.  The statistical correlation 
between these two assessment tools was strong (r = 0.83; p < 0.0001).  For purposes 
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of analysis, the categorical classification (mild, moderate, severe) based on the OPS 
was used to control for stroke severity. 
 Altered visual function was identified in 29.6% of subjects at the time of 
enrollment.  Of those with visual impairment, 63.2% experienced partial hemianopia, 
22.1% had complete hemianopia, and 14.7% had bilateral hemianopia or complete 
blindness.  Extinction or inattention was present in 19.0% of subjects at the time of 
enrollment.  Of these subjects, 73.8% demonstrated mild symptoms, and 26.2% had 
profound extinction or inattention. 
 Approximately half of subjects (52.7%) had minor degrees of comorbid 
disease based on the Charlson Comorbidity Index.  All subjects scored at least one 
point based on their history of stroke.  For 85 subjects (26.5%), the stroke was the 
only recorded disorder on this instrument.  More severe levels of comorbidity were 
observed in 47.4% of subjects, with 70.4% of them (107/152) scoring 3 or 4 points, 
24.3% (37/152) scoring 5 or 6 points, and 5.3% (8/152) scoring 7 or 8 points. 
At the time of study enrollment, 82 subjects (25.5%) were categorized as 
depressed based on a Geriatric Depression Scale score of more than 5 points.  
However, data for this variable were not available for 40 subjects (12.5%) at the 
initial evaluation.  At the baseline enrollment assessment, the mean Folstein MMSE 
score was 22.6 ± 7.7 points, with 34.6% of subjects categorized as cognitively 
impaired (score < 24 points). 
 
 
 34
Urinary Continence and Bladder Function 
 All 321 subjects were continent of urine (dry) and independent of bladder 
function prior to their stroke based on the pre-stroke Barthel Index score.  At the 
time of enrollment, 99 subjects (30.9%) were rated as incontinent (wet) of urine.  At 
the 6 month follow-up, 64 subjects (19.9%) were incontinent of urine.  This included 
44 subjects who were incontinent at enrollment and remained incontinent at the final 
examination, and 20 subjects who had been dry at the baseline evaluation but 
developed urinary incontinence over the 6 months of the study.  A total of 201 
subjects were dry at both the baseline and 6 month time points.  An improvement in 
bladder function was noted in 55 subjects who were incontinent at the enrollment 
examination but regained independent continence status at the 6 month evaluation.  
Bivariate analyses stratified by urinary bladder continence status at 6 months 
follow-up are summarized in Tables 2A and 2B.  The urinary incontinent group was 
significantly older (72.5 ± 10.5 years) than the dry group (67.4 ± 11.1 years) (p= 
0.001).  Higher prevalence of urinary incontinence was also associated with more 
severe stroke as measured by the Orpington Prognostic Scale (p < 0.001).  Based on 
categorical analysis, subjects who experienced a moderate stroke were 3.2 times 
more likely to have urinary incontinence at 6 months compared to those who 
experienced a minor stroke (95% CI = 1.68 – 6.27).  The effect was even more 
pronounced when comparing those who experienced a severe stroke to those with a 
minor stroke (OR = 5.0, 95% CI = 1.95 – 13.03).  After adjusting for stroke severity, 
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there was a 1.48 fold increase in urinary incontinence for each decade of increased 
age. 
Urinary incontinence was also associated with more pronounced levels of 
cognitive and functional impairment based on the mean Folstein MMSE scores and 
partial Barthel Index scores (both, p < 0.001).  After adjusting for stroke severity, no 
significant differences were observed between the continent and incontinent groups 
based on sex, race/ethnicity, stroke type, or stroke location.  Higher educational 
status (college or post-graduate school) was associated with better continence status 
(OR = 0.41, 95% CI = 0.18 – 0.94). 
When adjusted for stroke severity, bladder incontinence at the baseline 
evaluation was strongly associated with bladder incontinence at 6 months (OR = 
6.41, 95% CI = 3.29 – 12.49).  Bowel incontinence at baseline was also significantly 
associated with urinary incontinence at 6 months (OR = 2.27, 95% = CI 1.19 – 4.32).  
The other physical function domains examined in this study, including the ability to 
independently perform toilet transfers, walking, and dressing, were not significantly 
associated with urinary continence status at 6 months. 
Visual impairment was also associated with urinary incontinence (OR = 1.94, 
95% CI = 1.04 – 3.60).  However, in this cohort, extinction and inattention were not 
associated with urinary incontinence after adjusting for stroke severity (OR = 1.32, 
95% CI = 0.63 – 2.76).   
Based on multiple logistic regression modeling, age and urinary continence 
status in the first two weeks after stroke were independent predictors of urinary 
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incontinence at 6 months (Table 3).  Analysis revealed statistically significant main 
effects only.  No interaction terms were found to be significant predictors for 
subsequent urinary incontinence.  Other variables included in the model which did 
not emerge as independent predictors of urinary incontinence included sex, stroke 
severity, stroke type, comorbidity status, visual impairment, inattention/extinction or 
depression.  In addition, baseline fecal continence status, ability to perform toilet 
transfers, mobility, and independence for dressing were not independent predictors 
of urinary incontinence at 6 months after stroke. 
 
Fecal Continence and Bowel Function 
 All 321 subjects in this study were continent (dry) of stool and independent 
of bowel function based on their pre-stroke Barthel Index analysis.  At the initial 
enrollment examination, 83 subjects (25.9%) were incontinent (wet) of stool.  At the 
time of the final 6 month evaluation, 48 subjects had fecal incontinence, including 24 
who were also incontinent of stool at the enrollment examination, and 24 who had 
previously been dry but had deterioration of bowel function over the course of the 
study.  In contrast, 59 subjects who were incontinent at the enrollment examination 
had improvement in their fecal function and were continent of stool at the 6 month 
time point. 
Bivariate analyses stratified by bowel continence status at 6 months follow-
up are summarized in Tables 4A and 4B.  Subjects with fecal incontinence were 
significantly older (mean 73.9 ± 9.4 years) compared to those without bowel 
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problems (67.5 ± 11.2 years) (p = 0.0002).  Increased stroke severity was also 
significantly associated with fecal incontinence at 6 months (p < 0.0001).  Based on 
the categorical analysis, subjects who experienced a moderate stroke were 2.75 times 
more likely to have fecal incontinence compared to those who suffered a minor 
stroke (95% CI = 1.23 – 6.14).  The association was even stronger between severe 
stroke and subsequent fecal incontinence (OR = 16.92, 95% CI 6.20 – 46.18).  After 
adjusting for stroke severity, there was a 1.68 fold increase in fecal incontinence for 
each decade of increased age. 
Increased comorbidity, worse cognitive function, and worse overall 
functional status were each associated with higher rates of fecal incontinence (all, p 
< 0.001).  After adjusting for stroke severity, no significant associations were 
identified between fecal incontinence at 6 months and sex, race, stroke type, or 
stroke location.  Increased educational status was associated with a lower rate of  
fecal incontinence compared to those with a high school education (OR = 0.30, 95% 
CI = 0.10 – 0.87). 
Visual impairment was associated with a higher rate of fecal incontinence 
compared to those with normal vision (OR = 2.82, 95% CI = 1.41 – 5.65).  After 
adjusting for stroke severity, extinction and/or inattention was not associated fecal 
incontinence (OR = 1.19, 95% CI = 0.52 – 2.71). 
There did not appear to be an association between depression identified at 
baseline examination and fecal incontinence at 6 months (OR = 1.81, 95% CI = 0.84 
– 3.94).  In unadjusted bivariate analyses, all of the physical function parameters 
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examined in this study were associated with higher rates of fecal incontinence.  
However, after adjusting for stroke severity, only bladder function measured at 
baseline enrollment (OR = 2.44, 95% CI = 1.16 – 5.14) and loss of independent 
function for dressing (OR = 4.15, 95% CI = 1.13 – 15.24) were statistically 
associated with fecal incontinence.  Bowel function measured at baseline (adjusted 
OR = 1.95, 95% CI = 0.93 – 4.09) and toilet transfer independence (adjusted OR = 
3.29, 95% CI = 0.97 – 11.15) were both close to reaching statistical significance. 
Subjects who demonstrated less overall improvement in physical function 
were more likely to have persistent fecal incontinence at 6 months compared to those 
who had greater physical recovery.  The mean partial Barthel Index scores, 
excluding the continence variables, only increased from 24 ± 23.7 to 38 ± 28.3 (p = 
0.0092) in those who did not regain independent control of bowel function.  In 
contrast, subjects who were continent of stool at 6 months had more substantial 
improvement in overall function with an increase in mean scores from 42 ± 24.4 to 
72 ± 13.9 (p < 0.0001). 
 Multiple logistic regression modeling revealed age, stroke severity, visual 
impairment, and loss of independence of dressing ability at baseline to be 
independent predictors of fecal incontinence at 6 months (Table 5).  Only main 
effects were found to be statistically significant.  No interaction terms were 
significant predictors for subsequent fecal incontinence.  Other variables included in 
the models which did not emerge as independent predictors of fecal incontinence 
included sex, stroke type, comorbidity status, inattention/extinction, and depression. 
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In addition, baseline urinary and fecal continence status, ability to perform toilet 
transfers, and mobility were not independent predictors of urinary incontinence at 6 
months after stroke. 
 
Relationship of Bladder and Bowel Function at 6 Months 
Analysis of the relationship between bladder and bowel function at the final 
timepoint did reveal a statistically significant association between these conditions.  
Of the 321 subjects in the study, 237 (73.8%) were continent and independent of 
both bladder and bowel function at 6 months.  Thirty-six subjects (11.2%) had 
urinary incontinence only, 20 (6.2%) had fecal incontinence only, and 28 (8.7%) had 
dual urinary and fecal incontinence.  Based on unadjusted analysis, this relationship 
was quite strong (OR = 9.2, 95% CI = 4.7 – 18.1).  This association was maintained 
when adjusted for stroke severity (OR = 8.6, 95% CI = 4.0 – 18.3). 
Subjects with dual incontinence were older (mean age 74.8 ± 8.5 years) than 
those with a single type of incontinence (71.4 ± 11.3) or those who were continent 
and independent of both bladder and bowel (70.0 ± 11.0).  These subjects with dual 
incontinence also tended to have suffered more severe strokes, and had worse levels 
of depression, cognitive impairment, and physical disability at both baseline 
enrollment and at 6 month follow-up.  These data are summarized in Table 6. 
At the 6 month follow-up, 85 subjects (26.5%) were classified as depressed, 
including 46 who were depressed at the time of enrollment, 26 who were previously 
not depressed, and 13 for whom enrollment information on depression was missing.  
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At the baseline enrollment assessment, the mean Folstein MMSE score was 23 ± 7.7 
points, with 34.6% of subjects categorized as cognitively impaired (score < 24 
points).  During the course of the study, there was a general trend toward 
improvement in cognitive status.  At the 6 month follow-up, the mean Folstein 
MMSE score had increased to 25 ± 6.7 points, and only 18.7% of subjects were 
considered cognitively impaired.   Of the 111 subjects categorized as cognitively 
impaired at the time of enrollment, 61 (55.0%) were classified as non-impaired at the 
6 month follow-up examination.  Only 7 of the 197 subjects categorized as non-
impaired at the time of enrollment were found to be cognitively impaired at the 6 
month follow-up. 
Overall physical function also tended to improve substantially with time.  
The mean total Barthel Index score at the time of enrollment was 55 ± 29.0 points, 
and the mean partial Barthel Index score (excluding the continence variables) was 38 
± 25.1 points.  By the 6 month follow-up, the mean total and partial Barthel Index 
scores had improved to 85 ± 24.2 and 67 ± 20.7 respectively (both, p < 0.0001). 
Examination of the partial Barthel Index scores revealed a significant 
improvement in both groups of subjects over the 6 months of follow-up.  For those 
who were continent of urine at 6 months, the mean partial Barthel Index score 
improved from 42 ± 24.6 to 73 ± 13.7 (p < 0.0001).  In those who remained wet at 6 
months, these scores only improved from 28 ± 23.8 to 46 ± 28.6 (p = 0.0002).  This 
reflects a higher overall level of physical function in those subjects who are dry and 
independent of bladder function at 6 months.
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Discussion 
 
 Urinary and fecal incontinence occur in many stroke survivors.  The 
development of incident incontinence can be associated with other substantial 
morbidity and disability which can have significant negative impacts.  Identification 
of modifiable risk factors which influence continence outcomes could have 
important implications for post-stroke recovery.  In this cohort of otherwise 
relatively healthy community-dwelling subjects who suffered stroke, several 
interesting primary findings emerged. 
The observed rates of urinary and fecal incontinence both at baseline and at 6 
months in this cohort of subjects were lower than in other studies reported in the 
literature.  This finding may be a reflection of the overall health of the study subjects.  
Rates of comorbidity were lower than in other studies which could have influenced 
these outcomes.  Subjects also tended to do well with rehabilitation, and the most 
dramatic improvements were seen in the first 1 to 3 months of recovery (data not 
shown).  Most of the subjects in this study experienced mild or moderate stroke 
which is also generally associated with better clinical outcomes compared to more 
severe strokes. 
Second, in terms of urinary continence status, the development of incident 
urinary incontinence within the first 2 weeks after stroke was an independent 
predictor of persistent incontinence at 6 months.  This is an important finding 
because therapies targeted in an attempt to improve urinary continence status may be 
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helpful for these subjects.  Treatments to enhance urinary control could be actively 
pursued in subjects found to have new-onset incontinence in the immediate post-
stroke period.  The potential effects of targeted intervention are unclear, and 
additional research will be needed to examine this issue. 
In this study, increased age was also found to be an independent predictor of 
both urinary and fecal incontinence at 6 months.  Several factors could account for 
this finding.  Physiologic changes in the urinary bladder and bowel associated with 
aging may occur which were not captured by any of the variables analyzed in this 
study.  The multiple logistic regression analyses were developed using main effects 
modeling.  Although interactions were tested, it is possible that variables which 
might influence the relationship between age and continence outcomes were not 
examined in this analysis. 
Worse visual impairment after stroke appeared to be an independent predictor 
of bowel incontinence at 6 months follow-up.  This was most pronounced for 
subjects with bilateral hemianopia or blindness compared to those with normal vision 
or less profound visual loss.  The reason for this association is unclear.  Visual 
impairment may be a marker of other underlying disabilities not directly measured in 
this study which could influence fecal continence.  Again, future research on this 
association will be helpful to better understand these relationships. 
The ability to dress and undress independently appeared to be predictive of 
bowel continence status at 6 months.  Intuitively, it is logical that loss of the 
independent ability to adjust one’s clothing could influence continence status.  This 
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activity is essential for toileting, even in subjects who might use aides or devices 
such as a bedpan or bedside commode. 
Based on the logistic regression analysis, depression was not found to be an 
independent predictor of either urinary or fecal incontinence at 6 months after stroke.  
As previously described, forty subjects did not have depression data recorded at the 
time of baseline enrollment.  Separate models were created by assigning all of these 
subjects to either a depressed or non-depressed category.  However, this did not 
affect the observed outcomes.  Other researchers have identified associations 
between depression and continence even in subjects who have not experienced 
stroke.58, 59  This may be due to biochemical factors which can influence both mood 
and bladder or bowel function.  These differences in findings may be influenced by 
how depression is diagnosed and categorized. 
In this cohort, the presence of symptoms of extinction or inattention was not 
found to be an independent predictor of urinary or fecal incontinence at 6 months.  
However recent data published by a Norwegian research group suggests that 
extinction and inattention may be important factors associated with some forms of 
post-stroke urinary incontinence.60, 61  These authors concluded that this condition 
may cause a form of urinary incontinence associated with a diminished sense of 
awareness of the need to void.  Potential treatment techniques could include 
prompted voiding or toileting of subjects with this problem in an attempt to improve 
continence outcomes.  Additional prospective clinical trials will be necessary to help 
better understand this specific condition. 
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Several other findings from this study deserve additional consideration.  In 
general populations of older adults, urinary incontinence tends to be more prevalent 
in women than men.  The role of gender differences in stroke outcomes has not been 
completely elucidated, but there appears to be little difference in most general 
outcomes.  This study enrolled a sizeable proportion of men in comparison to the 
population demographics for older adults.  This may be a reflection of the fact that 
younger subjects were included in this study.  It may also be due to the fact that two 
of the twelve healthcare facilities in this study were Veterans Affairs hospitals, 
which tend to have larger numbers of male patients. 
Persistent urinary incontinence which develops after acute stroke has been 
identified as a potential marker for post-stroke mortality.  However, the design of 
this study precluded modeling of a survival analysis.  Overall, only 32 subjects of the 
original 459 were known to have died after their stroke.  An additional 37 refused to 
continue participation at some point prior to the final 6 month follow-up visit, 12 had 
moved, and 1 subject was lost to follow-up.  Mortality has also been closely linked to 
stroke severity in most studies.  This study had a smaller proportion of subjects who 
suffered a severe stroke, and this may account for the low overall mortality observed 
in this cohort. 
 A ceiling effect was observed in this study with regard to the association 
between independent predictor variables and continence outcomes.  Most subjects 
suffered either a minor or moderate stroke, and tended to have substantial overall 
functional recovery with time.  This was particularly noticeable at the 1 month and 3 
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month timepoints (data not shown).  Therefore, the observed rates of urinary and 
fecal incontinence at the 6 month timepoint were relatively low for the total study 
population.  This suggests that successful overall post-stroke rehabilitation may be 
associated with improvements in urinary and fecal continence status.  In contrast, 
those subjects with the most profound impairments in physical and cognitive 
function were more likely to suffer from dual urinary and fecal incontinence at the 6 
month evaluation. 
 This study has several unique strengths.  The inclusion and exclusion criteria 
for the secondary analysis were designed to limit the investigation to incident urinary 
and fecal incontinence which developed due to the acute stroke.  This was possible 
only because questions had been asked about pre-stroke continence status using the 
Barthel Index.  A total of 73 subjects were excluded because they had either isolated 
urinary or fecal incontinence or dual incontinence prior to their stroke.  This is rare 
in the stroke outcomes literature because most studies do not attempt to separate 
subjects with a history of incontinence prior to stroke.  It can be quite difficult to 
interpret the differences between incident incontinence and progression of prior 
disease.  However, this could also be considered a potential limitation of the current 
study because these individuals were excluded from the overall analysis. 
 Another strength of this study was the use of strict definitions of continence 
for both bladder and bowel function.  Subjects had to be dry and fully independent of 
function in order to be classified as continent.  Although this will lead to a rather 
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conservative assessment of continence status, it may be associated with a greater 
tendency toward a ceiling effect for this variable in the outcomes analysis. 
This study examined a prospective cohort of community dwelling adults who 
were relatively healthy prior to their stroke.  Most subjects lived within the Kansas 
City metropolitan area.  Therefore, there was relatively small subject loss to follow-
up, and there was limited missing data for most of the variables examined in this 
analysis.  Multiple measures were performed at each evaluation timepoint using 
standardized, validated assessment instruments.  This helped in the development of 
relevant questions and interpretation of findings. 
This study also has several important limitations.  The strict inclusion and 
exclusion criteria led to elimination of 138 subjects from the analysis.  Seventy-three 
of these subjects had urinary and/or fecal incontinence prior to their stroke.  Once 
these subjects had been eliminated, only 30.9% of subjects had urinary incontinence 
at the time of baseline enrollment examination, and 25.9% had fecal incontinence.  
These numbers are substantially lower than most data reported in the literature, 
which suggest that up to 50 – 70% of acute stroke survivors may develop urinary 
incontinence.62-64  The observed rate of fecal incontinence was similar to that 
previously reported in the stroke outcomes literature.  However, even considering the 
total population of subjects enrolled in the Kansas City Stroke Study, the overall 
observed rate of urinary incontinence (34.2%) was relatively low. 
 The bladder and bowel function questions from the Barthel Index were used 
as the dependent outcome variables in this study.  In addition, the independent 
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variables for physical function were measured using this instrument.  However, the 
Barthel Index may not be the most sensitive tool to use for this purpose, particularly 
when looking for changes over a relatively short time. 
 There are a variety of comorbid conditions which can influence urinary 
and/or fecal continence status in both men and women.  Examples include prostate 
disease or prior prostate surgery in men, increased parity or pelvic organ prolapse in 
women, or a history of pelvic radiation in both sexes.5, 6, 65  Recent studies have also 
shown associations between obstructive sleep apnea and both nocturia and nocturnal 
incontinence.66-68  In addition, some classes of medication such as diuretics, 
narcotics, alpha-adrenergic antagonists, or angiotensin converting enzyme (ACE) 
inhibitors can predispose subjects to urinary incontinence.69-71  Unfortunately, 
individual data for these conditions and medications were not available in this 
analysis.  It is possible that the urinary and fecal incontinence observed in some 
individuals may have been caused by one of these underlying factors rather than the 
direct effects of the stroke. 
Stroke progression in the immediate post-event interval occurs in 
approximately 3 – 8 % of patients72, and recurrent stroke occurs in 9 – 16% of 
subjects.73  This phenomenon was not examined in the current study.  It is possible 
that stroke progression or recurrence may affect clinical outcomes with regard to 
continence status.  It would be particularly interesting to determine if stroke 
progression or recurrent stroke occurred in those subjects who demonstrated a 
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deterioration of either continence outcomes or other functional abilities during the 
course of this study. 
Living status at the 6 month follow-up was not assessed in this secondary 
data analysis.  Urinary and fecal incontinence are generally associated with higher 
rates of nursing home and other institutional care.  If available, it would be intriguing 
to add this data to the analysis to determine if continence status in this cohort was 
associated with subsequent place of residence.  Successful efforts to improve 
continence could lead to changes in healthcare utilization rates and the costs of post-
stroke care. 
 Because no specific data were available, it was not possible to determine a 
physiologic cause or subtype of incontinence experienced by a given individual.  The 
most common form of urinary incontinence after stroke is urge incontinence 
secondary to an overactive detrusor.  However, some patients experience urinary 
retention with overflow incontinence after stroke.  The instruments used to measure 
incontinence in this study did not permit distinction between these various forms of 
incontinence.  Additionally, no urodynamic data or information on post-void residual 
volumes were available in this cohort.  Inclusion of these measures in future studies 
would permit this type of analysis which could have important implications. 
 In addition, there were no data available to know whether individual subjects 
had undergone any type of therapy targeted at improving either urinary or fecal 
incontinence.  The importance of post-stroke rehabilitation has been examined in a 
variety of prior studies of overall function.74-77    It would be helpful in future 
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research to know if subjects had received any type of medical, surgical, or 
biobehavioral therapy targeted at improving their urinary and/or fecal continence 
status. 
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Future Directions 
 
 This study used fixed timepoints for the assessment of the independent 
predictor variables and the dependent outcome variables.  Measurements were 
obtained at the time of study enrollment (within 14 days after the stroke).  The 
dependent variables of urinary and fecal continence status were measured at the 6 
month assessment for this analysis.  However, data are also available for the 1 month 
and 3 month timepoints.  It would be interesting to analyze the fluidity of those 
variables which can change with time, particularly in the early recovery phase.  As 
was noted in this study, many subjects experience dramatic improvement in function 
for some clinical parameters, and this was most pronounced in the first months after 
stroke. 
Other outcomes measures may provide a method to obtain a finer level of 
detail regarding urinary and fecal continence status as well as other levels of 
functional ability.  The Functional Independence Measure™ (FIM) is an 18 item 
instrument which measures physical function using a seven level ordinal rating scale.  
This tool includes questions on bladder and bowel management.  In addition, it has 
items that examine toileting and toilet transfers, bathing, tub and shower transfers, 
mobility, and dressing either the upper or lower half of the body.  Subjects are 
graded on the level of independence for each item from 1 point if they require total 
assistance to perform the activity to 7 points if they are completely independent.  
Intermediate scores indicate the need for various levels of assistance, supervision, or 
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modifications to perform the task.  The FIM was administered at the baseline 
enrollment examination, and at the 1, 3, and 6 month follow-up examinations in the 
Kansas City Stroke Study cohort.  Pre-stroke abilities were not assessed using this 
instrument.  However the FIM may be more sensitive to change over time with 
regard to these clinical parameters. 
Several of the independent variables were measured using multiple questions 
or assessment items.  For example, the Geriatric Depression Scale uses yes/no 
questions to test for signs of depression, and the Folstein MMSE uses multiple 
questions to assess cognitive status across several domains.  An examination using 
the component subscores for these types of instruments might prove useful in better 
understanding the complex relationships between these clinical conditions and 
continence outcomes. 
It would also be interesting to repeat this type of analysis with a different 
cohort of subjects.  This would help to verify the findings from this study, and may 
lead to additional information depending on the specific measurement instruments 
included in the dataset.  Additional follow-up beyond the 6 month timepoint would 
also be useful.  As observed in this analysis, there is often a dramatic improvement in 
overall function which occurs in the first several months following an acute stroke.  
However, 6 months is probably not adequate to fully assess the impact of urinary or 
fecal incontinence on other clinical outcomes.  Continued improvement, or perhaps 
deterioration of function, might be observed with additional time.
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Conclusions 
 
 Urinary and fecal incontinence are common symptomatic sequelae after acute 
stroke.  Many stroke survivors demonstrate significant improvement in functional 
status, including both bladder and bowel function, in the first 6 months after stroke. 
Increased age and bladder function immediately following stroke is predictive of 
urinary incontinence at 6 months.  Increased age, worse stroke severity, visual 
impairment, and loss of independent ability to dress and undress are predictive of 
fecal incontinence at 6 months.  Additional research will help to identify how these 
predictive clinical variables may be used to direct care decisions and rehabilitation 
for stroke survivors. 
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321  remaining subjects 
        (retained cohort) 
386  remaining subjects 
73 subjects incontinent (not independent) of 
     bladder and/or bowel prior to stroke 
• 46 incontinent of urine only 
• 15 incontinent of stool only 
• 12 incontinent of both urine and stool 
 
• 55 completed 6 month follow-up 
• 18 did not complete 6 month follow-up 
o 9 died 
o 4 refused 
o 5 moved 
65 subjects continent (independent) of both 
     bladder and bowel prior to stroke 
• 64 did not complete 6 month follow-
up 
o 23 died 
o 33 refused 
o   7 moved 
o   1 unknown 
 
• 1 completed 6 month follow-up but 
continence outcomes data missing 
459  initial total subjects 
 
 
Figure 3 – Flowchart of Patient Inclusion / Exclusion for Current Study
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